HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California Will Prohibit Use Of Some Cosmetic Ingredients Banned In Europe Beginning in 2025

Executive Summary

Starting in 2025, use of selected preservatives, phthalates and other ingredients already banned in Europe will be prohibited in cosmetics sold in California.

You may also be interested in...



California’s PFAS Ban In Cosmetics Limited To Intentionally Added Substances, Effective In 2025

Legislation awaiting the governor’s signature in California will ban the “forever chemicals” from cosmetics when intentionally added beginning in 2025, reflecting successful industry advocacy efforts.

California DTSC Nominates TPHP In Nail Products As Possible Priority For Alternatives Analysis

California is taking a closer look at the safety of four potentially harmful ingredients in nail products and has named triphenyl phosphate specifically as a possible Priority Product under the state’s Safer Consumer Products regulation.

Industry Pushes For Revised PFAS Definition In California Bill Seeking Cosmetic Ban

The Personal Care Products Council and other industry groups suggest they will support AB 2771 if amendments are made to promote international harmonization, among other changes. Already they advocated successfully for the bill’s scope to be limited to intentionally added PFAS, not “the mere presence of trace levels of fluorine in the product.”

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS150526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel